Avidity Biosciences, Inc (RNAM) — Capital Reinvestment Ratio
Avidity Biosciences, Inc (RNAM) has a Capital Reinvestment Ratio of 0.05x as of December 2023, meaning it reinvests 0% of its operating cash flow ($16.50 Million) in capital expenditures ($863.00K). See debt-free asset ratio of Avidity Biosciences, Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Avidity Biosciences, Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Avidity Biosciences, Inc's Capital Reinvestment Ratio across 1 annual periods. Check Avidity Biosciences, Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Avidity Biosciences, Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Avidity Biosciences, Inc from 2019 to 2019. For live market cap and broader valuation context, see market cap of Avidity Biosciences, Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.09x | $2.49 Million | $235.00K | — |